Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPC-6535 in active ulcerative colitis
NCT00317356Phase 2Terminated
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tetomilast in ulcerative colitis (UC), sponsored by Otsuka Pharmaceutical Co., Ltd.. Started May 2006; status: terminated.
02
Drugs
tetomilast
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT00317356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00317356.